This inventor holds 3 USPTO granted patents. Top assignee: Asama Chemical Co., Ltd.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2002
Title: Yasuki Fukuda: Innovator in Immunomodulation
Introduction
Yasuki Fukuda is a prominent inventor based in Gifu, Japan. He has made significant contributions to the field of immunomodulation, holding a total of 3 patents. His work focuses on developing innovative solutions that enhance immune responses through novel delivery methods.
Latest Patents
Fukuda's latest patents include groundbreaking inventions such as an immunomodulator, immunomodulator food, and immunomodulator feed. These inventions aim to provide an immunomodulator that can be administered orally or percutaneously, rather than through traditional injection methods. The immunomodulator is designed to be taken daily like food, utilizing DNA derived from prokaryotic cells, such as lactic acid bacteria and amino acid-producing bacteria. This DNA can be added to food or molded for oral, percutaneous, or permucosal administration. Additionally, he has developed antimicrobial agents for eukaryotic microorganisms, which include a composition effective against various eukaryotic microorganisms. This antimicrobial composition can be safely incorporated into food and cosmetic products.
Career Highlights
Fukuda is associated with Asama Chemical Co., Ltd., where he continues to innovate in the field of immunomodulation. His work has garnered attention for its potential applications in health and nutrition.
Collaborations
He has collaborated with notable colleagues, including Kousaku Murata and Mizuo Yajima, to further advance his research and development efforts.
Conclusion
Yasuki Fukuda's contributions to immunomodulation through his innovative patents highlight his role as a leading inventor in this field. His work not only enhances our understanding of immune responses but also paves the way for new health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile